크로마토그래피 시약 : 시장 점유율 분석, 업계 동향 및 통계, 성장 예측(2026-2031년)

According to Mordor Intelligence, the chromatography reagents market size is estimated at USD 12.58 billion in 2026, and is expected to reach USD 17.32 billion by 2031, at a CAGR of 6.61% during the forecast period (2026-2031).

This report is Segmented by Type (Buffers, Ion Pair Reagents, Solvents, and Other Types), Physical State of Mobile Phase (Gas, Liquid, and Super-Critical Fluid), Technology (Ion Exchange, Affinity Exchange, Size Exclusion, and More), Application (Pharmaceutical, and More), and Geography (Asia-Pacific, North America, and More). The Market Forecasts are Provided in Terms of Value (USD).

Global Chromatography Reagents Market Trends and Insights

Rising Demand from Pharmaceutical and Biotech Manufacturing

Between 2024 and 2025, global CDMOs expanded their single-use bioreactor capacity. Each batch requires capture and polishing buffers, resulting in a buffer-to-product ratio and ensuring consistent reagent demand. While the disposable column format streamlines the process by eliminating the need for cleaning validation, it also increases per-batch reagent costs, as these columns are typically discarded after a limited number of cycles. Furthermore, new FDA guidelines on continuous biologics manufacturing mandate that QC labs conduct chromatography assays frequently, leading to a significant increase in solvent throughput compared to traditional batch releases. In the Asia-Pacific region, CDMOs are rapidly expanding their capacities. Notably, South Korea and India have made substantial investments in chromatography-enabled suites during 2024-2025, bolstering the global presence of the chromatography reagents market. These strategic expansions are pivotal in supporting the anticipated growth of overall revenue.

Expanding Research and Development Budgets in Biotechnology and Life-Science Institutes

In 2025, global funding for life-science research and development reached significant levels. Notably, programs in proteomics and metabolomics are consuming a substantial share of LC-MS solvents, buffers, and standards. As universities transition from manual HPLC benches to round-the-clock automated UHPLC platforms, reagent consumption per instrument has surged. Horizon Europe, with an eye on the future, allocated funds for molecular medicine initiatives through 2025. A key stipulation was the use of standardized chromatography methods with certified solvents, further bolstering the chromatography reagents market. In a notable move, China's science foundation amplified its analytical-chemistry grants in 2025. Many of these projects are pivoting towards greener mobile phases, which, paradoxically, is driving a short-term spike in reagent purchases for method validation. Meanwhile, private biotech startups are increasingly turning to CROs for method development. These CROs, while securing volume discounts, are also prioritizing suppliers that offer just-in-time deliveries, a strategy aimed at minimizing inventory carrying costs.

High Cost of High-Purity Reagents and Volatile Raw-Material Pricing

In 2025, LC-MS-grade acetonitrile commanded significantly higher prices than its technical-grade counterpart. This premium pricing is largely due to stringent producer requirements, mandating sub-1 ppb elemental contamination levels. Pricing fluctuations in raw materials are not merely incidental; they are deeply rooted in the production process. Acetonitrile is predominantly a by-product of propylene-based acrylonitrile production, making its pricing susceptible to the inherent volatilities of the petrochemical market. In 2024, disruptions caused by hurricanes led to a reduction in output from the U.S. Gulf Coast. This shortfall compelled distributors to ration their allocations, nudging smaller laboratories to pivot towards methanol as a substitute. However, this switch came with a trade-off: longer run times.

Other drivers and restraints analyzed in the detailed report include:

1. Stricter Global Food-Safety and Environmental-Testing Regulations
2. Shift to MS-Coupled HILIC Methods Requiring Ultra-Low-Metal Reagents
3. Persistent Acetonitrile Supply Shocks and Price Volatility

For complete list of drivers and restraints, kindly check the Table Of Contents.

Segment Analysis

Ion pair reagents recorded a 6.75% CAGR outlook to 2031, outpacing the broader chromatography reagents market size, as peptide and oligonucleotide pipelines grow. Solvents still dominate revenue and captured a 52.75% chromatography reagents market share in 2025, but per-analysis volumes are slipping as gradient optimization and narrow-bore columns shorten equilibration times.

As single-use bioprocessing prioritizes lot-to-lot consistency, the demand for pre-formulated GMP buffers remains robust. Suppliers are setting themselves apart by offering just-in-time delivery and consignment stock programs, alleviating the working-capital pressures faced by CDMOs. While volatile ion-pairing agents facilitate MS-compatible separations, they necessitate corrosion-resistant titanium flow paths. This requirement carves out a distinct growth trajectory within the chromatography reagents market.

Gas chromatography reagents are set for a 7.20% CAGR to 2031, the fastest among physical-state segments, helped by EU and U.S. rules expanding pesticide and VOC screening that depend on two-dimensional GC-MS workflows. Liquid chromatography reagents retained 82.56% of 2025 revenue, anchored by pharmaceutical QC and bioprocess PAT applications.

In 2024, regulators revised the Industrial Emissions Directive, reducing VOC discharge limits. This move necessitated real-time GC monitoring, which now demands carrier gases and calibration standards at significantly higher rates than historical norms. While SFC reagents occupy a niche, they offer a substantial reduction in solvents. This aligns with sustainability mandates, even if they lack widespread recognition in pharmacopeias. The growing adoption of GCxGC in flavor and fragrance analytics is driving up the demand for derivatization chemicals and ultra-high-purity helium, further diversifying the physical phases of the chromatography reagents market.

Complete Report Scope:

• By Type
  • Buffers
  • Ion Pair Reagents
  • Solvents
  • Other Types
• By Physical State of Mobile Phase
  • Gas Chromatography Reagents
  • Liquid Chromatography Reagents
  • Super-Critical Fluid Chromatography Reagents
• By Technology
  • Ion Exchange
  • Affinity Exchange
  • Size Exclusion
  • Hydrophobic Interaction
  • Mixed-Mode
  • Other Technologies
• By Application
  • Pharmaceutical
  • Food and Beverages
  • Water and Environmental Analysis
  • Other Applications
• By Geography
  • Asia-Pacific
    • China
    • India
    • Japan
    • South Korea
    • ASEAN Countries
    • Rest of Asia-Pacific
  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • Germany
    • United Kingdom
    • Italy
    • France
    • Spain
    • NORDIC Countries
    • Rest of Europe
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Middle-East and Africa
    • Saudi Arabia
    • South Africa
    • Rest of Middle-East and Africa

Geography Analysis

North America accounted for 46.82% of 2025, driven by robust demand. The U.S., housing a significant portion of the world's biologics capacity, enforces stringent cGMP regulations, emphasizing the need for traceable and validated reagents. Regional CDMOs are increasingly adopting pre-formulated buffers, streamlining batch processes, and enhancing solvent and buffer throughput. Canada's cannabis testing regulations, expanded in 2024, now account for additional monthly chromatography runs, heavily utilizing derivatization reagents and LC-MS solvents. Meanwhile, Mexico is emerging as a prominent near-shoring hub, evidenced by a rise in its API exports to the U.S. in 2025, subsequently driving up demand for HPLC solvents.

Europe is projected to grow the fastest at an 8.21% CAGR through 2031. This momentum is largely attributed to revisions by the EMA, which halved the permissible limits on elemental impurities. These changes have mandated a widespread shift to ultra-low-metal solvents across the industry, bolstering the market size for chromatography reagents. In Germany, the Fraunhofer Institute has initiated pilot continuous chromatography facilities, utilizing custom buffers monthly during their optimization phase. The UK's MHRA is championing single-use technology in cell therapies, leading to increased buffer volumes. Concurrently, Sweden's KEMI is urging labs to phase out halogenated solvents by 2028, driving a shift towards ethanol-water systems.

The Asia-Pacific region showcases a mixed landscape. In 2025, China's NMPA greenlit new biologics plants, contributing additional single-use bioreactor capacity and subsequently boosting demand for chromatography reagents. Japan's pharmacopoeia has begun endorsing UHPLC across several monographs. While the transition from 4.6 mm to 2.1 mm columns has achieved a significant reduction in solvent volume per run, the overall solvent volumes remain consistent due to increased sample throughput. South Korea's industry giants, Samsung Biologics and Celltrion, have collectively augmented their biosimilar capacity through 2025, leading to heightened orders for protein A resin. Singapore, on the other hand, has witnessed an uptick in biopharma output, with chromatography consumables constituting a notable portion of production costs. This diverse regional activity underscores the long-term robustness of the chromatography reagents market.

1. Agilent Technologies Inc.
2. Avantor Inc.
3. Bio-Rad Laboratories Inc.
4. DH Life Sciences, LLC.
5. ITW Reagents
6. Merck KGaA
7. PerkinElmer
8. Regis Technologies Inc.
9. Repligen Corporation.
10. Santa Cruz Biotechnology Inc.
11. Shimadzu Corporation
12. Spectrum Chemical Mfg.
13. Thermo Fisher Scientific Inc.
14. Tokyo Chemical Industry
15. Tosoh Corporation
16. Waters Corporation

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

TABLE OF CONTENTS

1 Introduction

• 1.1 Study Assumptions and Market Definition
• 1.2 Scope of the Study

2 Research Methodology

3 Executive Summary

4 Market Landscape

• 4.1 Market Overview
• 4.2 Market Drivers
  • 4.2.1 Rising demand from pharmaceutical and biotech manufacturing
  • 4.2.2 Expanding research and development budgets in biotechnology and life-science institutes
  • 4.2.3 Stricter global food-safety and environmental-testing regulations
  • 4.2.4 Shift to MS-coupled HILIC methods requiring ultra-low-metal reagents
  • 4.2.5 Continuous single-use bioprocessing boosting buffer and single-shot solutions
• 4.3 Market Restraints
  • 4.3.1 High cost of high-purity reagents and volatile raw-material pricing
  • 4.3.2 Persistent acetonitrile supply shocks and price volatility
  • 4.3.3 Solvent-reduction/green-chemistry workflows lowering per-sample volumes
• 4.4 Value Chain Analysis
• 4.5 Porter's Five Forces
  • 4.5.1 Bargaining Power of Suppliers
  • 4.5.2 Bargaining Power of Buyers
  • 4.5.3 Threat of New Entrants
  • 4.5.4 Threat of Substitutes
  • 4.5.5 Degree of Competition

5 Market Size and Growth Forecasts (Value)

• 5.1 By Type
  • 5.1.1 Buffers
  • 5.1.2 Ion Pair Reagents
  • 5.1.3 Solvents
  • 5.1.4 Other Types
• 5.2 By Physical State of Mobile Phase
  • 5.2.1 Gas Chromatography Reagents
  • 5.2.2 Liquid Chromatography Reagents
  • 5.2.3 Super-Critical Fluid Chromatography Reagents
• 5.3 By Technology
  • 5.3.1 Ion Exchange
  • 5.3.2 Affinity Exchange
  • 5.3.3 Size Exclusion
  • 5.3.4 Hydrophobic Interaction
  • 5.3.5 Mixed-Mode
  • 5.3.6 Other Technologies
• 5.4 By Application
  • 5.4.1 Pharmaceutical
  • 5.4.2 Food and Beverages
  • 5.4.3 Water and Environmental Analysis
  • 5.4.4 Other Applications
• 5.5 By Geography
  • 5.5.1 Asia-Pacific
    • 5.5.1.1 China
    • 5.5.1.2 India
    • 5.5.1.3 Japan
    • 5.5.1.4 South Korea
    • 5.5.1.5 ASEAN Countries
    • 5.5.1.6 Rest of Asia-Pacific
  • 5.5.2 North America
    • 5.5.2.1 United States
    • 5.5.2.2 Canada
    • 5.5.2.3 Mexico
  • 5.5.3 Europe
    • 5.5.3.1 Germany
    • 5.5.3.2 United Kingdom
    • 5.5.3.3 Italy
    • 5.5.3.4 France
    • 5.5.3.5 Spain
    • 5.5.3.6 NORDIC Countries
    • 5.5.3.7 Rest of Europe
  • 5.5.4 South America
    • 5.5.4.1 Brazil
    • 5.5.4.2 Argentina
    • 5.5.4.3 Rest of South America
  • 5.5.5 Middle-East and Africa
    • 5.5.5.1 Saudi Arabia
    • 5.5.5.2 South Africa
    • 5.5.5.3 Rest of Middle-East and Africa

6 Competitive Landscape

• 6.1 Market Concentration
• 6.2 Strategic Moves
• 6.3 Market Share(%)/Ranking Analysis
• 6.4 Company Profiles (includes Global level Overview, Market level overview, Core Segments, Financials, Strategic Information, Products and Services, Recent Developments)
  • 6.4.1 Agilent Technologies Inc.
  • 6.4.2 Avantor Inc.
  • 6.4.3 Bio-Rad Laboratories Inc.
  • 6.4.4 DH Life Sciences, LLC.
  • 6.4.5 ITW Reagents
  • 6.4.6 Merck KGaA
  • 6.4.7 PerkinElmer
  • 6.4.8 Regis Technologies Inc.
  • 6.4.9 Repligen Corporation.
  • 6.4.10 Santa Cruz Biotechnology Inc.
  • 6.4.11 Shimadzu Corporation
  • 6.4.12 Spectrum Chemical Mfg.
  • 6.4.13 Thermo Fisher Scientific Inc.
  • 6.4.14 Tokyo Chemical Industry
  • 6.4.15 Tosoh Corporation
  • 6.4.16 Waters Corporation

7 Market Opportunities and Future Outlook

• 7.1 White-space and Unmet-Need Assessment